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China’s national 12th Five-Year Plan (2011-2015) stated
that, by 2015, China should increase the average life
expectancy by one year (estimated to reach 74.5 years old)
relative to that of 2010. Additionally, China’s new around
of health reform was initiated in 2009. Translational medi-
cine, which is moving basic discoveries in the laboratories
into human studies to promote new preventions, diagnos-
tics, treatments and cures, is the engine to the health care
reform and the proposed life expectancy increase. The
potential of translational medicine in China has never
been greater.
Starting in 2005, translational research centers began to
spontaneously appear in China. Since 2009, more and
more centers have been emerged. Currently, translational
centers are founded most independently by local cities,
universities and hospitals. There’s a lack of policy support
and guidance, funding support, resource standardization
and sharing. We are still in the exploratory stage. To find
better diagnostics and treatments, China’s translational
medicine focuses more on innovations and how to push
laboratory discoveries to clinical practice. Guided by the
concept of “cure a disease before its onset”, China’s trans-
lational medicine also puts more effort on public health.
As part of translational medicine initiative, China already
supported many translational medicine projects during the
11th and 12th Five-Year Plans through National High-Tech
R&D Program of China (863 Program), 973 project and
National Nature Science Foundation.
As a developing country with 1.3 billion people, China
faces many challenges to promote translational medicine
and health care reform.
♦ How to combine translational medicine with basic
research, clinical medicine and public health?
♦ How does translational medicine better serve China
health care reform?
♦ How to further develop traditional Chinese medi-
cine (TCM) through translational medicine?
♦ How to evaluate translational centers and transla-
tional medicine programs?
To build a modern health service system and better
serve the society, China should list digital health as a
priority to develop. Additionally, I would like to suggest
that more emphasis should be placed on the establish-
ment of translational medicine-related policies, laws and
regulations, resource standardization and sharing. Look-
ing forward, translational medicine is a revolutionary
opportunity for China.
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